CSIMarket
 


La Jolla Pharmaceutical Company  (LJPC)
Other Ticker:  
 

Cumulative La Jolla Pharmaceutical's Quick Ratio for Trailing Twelve Months Period

LJPC's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LJPC Quick Ratio for Trailing Twelve Months Period

(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Current Liabilities Growth 3.51 % 39.4 % -41.12 % -10.91 % -10.91 %
Y / Y Cash & cash equivalent Growth 6.04 % 15.34 % 119.91 % 68.46 % -35.74 %
Quick Ratio for Trailing Twelve Months Period 3.36 3.35 3.53 2.75 2.33
Total Ranking # 1319 # 1395 # 1363 # 1132 # 1236
Seq. Current Liabilities Growth 2.77 % 124.64 % -54.88 % -0.62 % 38.4 %
Seq. Cash & cash equivalent Growth 9.21 % -4.52 % -0.21 % 1.91 % 18.78 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2022
On the trailing twelve months basis La Jolla Pharmaceutical Company Cash & cash equivalent average improved by 6.04% in II. Quarter year on year, faster than Current Liabilities, this led to increase in in La Jolla Pharmaceutical's Quick Ratio for Trailing Twelve Months Period to 3.36, Quick Ratio for Trailing Twelve Months Period remained below La Jolla Pharmaceutical Company average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 127 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than La Jolla Pharmaceutical. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about LJPC
Quick Ratio LJPC in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 128
Sector # 672
S&P 500 # 1255


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
14.69 6.46 2.27
(Jun 30 2017)   (Jun 30 2021)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2022, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Recursion Pharmaceuticals Inc   9.10 
Tracon Pharmaceuticals Inc   8.88 
Iovance Biotherapeutics Inc   8.87 
Cel sci Corporation  8.84 
Checkmate Pharmaceuticals Inc   8.55 
Dyadic International Inc  8.45 
Surface Oncology Inc   8.42 
Invivyd Inc   8.12 
C4 Therapeutics Inc   8.06 
Ikena Oncology Inc   7.96 
Senti Biosciences Inc   7.89 
Vectivbio Holding Ag  7.73 
Tscan Therapeutics Inc   7.65 
Sana Biotechnology Inc   7.54 
Biondvax Pharmaceuticals Ltd   7.50 
Oyster Point Pharma Inc   7.45 
Bioatla Inc   7.42 
Inhibrx Inc   7.30 
Jasper Therapeutics Inc   7.15 
Twist Bioscience Corporation  7.11 
Compugen Ltd  6.94 
Ambrx Biopharma Inc   6.92 
Biomx Inc   6.47 
Aceragen Inc   6.44 
Sophia Genetics Sa  6.39 
Relay Therapeutics Inc   6.10 
Cardiol Therapeutics inc   6.07 
Creative Medical Technology Holdings Inc   6.05 
Biocardia Inc  6.03 
Old Ayala Inc   5.84 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com